English | Spanish
ecancer
Login Register
The content on this site is intended for healthcare professionals only
  • Home
  • News
  • Journal
  • Video
  • elearning
  • Conferences
  • About us
Breast
Prostate & urology
Lung & pleura
Colorectal & gastro
Melanoma & skin
Head & neck
Ovary & gynaecology
+ -
Bone
Brain & nervous system
Haematology oncology
Hepatobiliary pancreatic
Paediatric
Neuroendocrine
Sarcomas

ecancer and the City Cancer Challenge have formed an educational collaboration. Learners who are part of the City Cancer Challenge's project can access additional education provided by them.

Please login or register. Then you can use this button to confirm you are part of this project.
Register for free Already have an account? Login
Videos [125]
News [264]
Articles [44]
Editorials [2]
Conferences [42]
elearning [2]
New marker, new target in Ewing's sarcoma
New marker, new target in Ewing's sarcoma
Targeted therapy with pazopanib prolongs progression-free survival in advanced soft-tissue sarcoma
Targeted therapy with pazopanib prolongs progression-free survival in advanced soft-tissue sarcoma
Common signs of cancer missed in a third of UK young people
Common signs of cancer missed in a third of UK young people
AACR 2012: Caffeine and exercise may be protective against skin cancer caused by sun exposure
AACR 2012: Caffeine and exercise may be protective against skin cancer caused by sun exposure
AACR 2012: Immunotherapy and chemotherapy regimen may prolong survival in advanced cancers
AACR 2012: Immunotherapy and chemotherapy regimen may prolong survival in advanced cancers
AACR 2012: Combination targeted therapy well tolerated, effective for refractory Ewing’s sarcoma tumours
AACR 2012: Combination targeted therapy well tolerated, effective for refractory Ewing’s sarcoma tum...
Cancer therapy gets personal
Cancer therapy gets personal
Researchers find sarcoma tumour immune response with combination therapy
Researchers find sarcoma tumour immune response with combination therapy
 New estimates predict nearly 1.3 million deaths from cancer in the EU in 2012, but the rate of people dying from the disease is declining
New estimates predict nearly 1.3 million deaths from cancer in the EU in 2012, but the rate of peop...
Vismodegib approved by the FDA for advanced basal cell carcinoma
Vismodegib approved by the FDA for advanced basal cell carcinoma
<1...2324252627>

More from ecancer

Stay up to date with our ecancer newsletter

Learn more

Explore patient resources at ecancerpatient

Visit site

Find out more about ecancer and the work we do

Learn more

Support ecancer's work by making a donation

  • Contact
  • Projects
  • Cookie Policy
  • Terms of Use
  • Privacy Policy
  • Follow ecancer on Facebook
  • Follow ecancer on Twitter
  • Follow ecancer on Linkedin
  • Subscribe to the ecancer YouTube channel
© 2022 ecancer, all rights reserved
UK registered charity number: 1176307